Immune Gene Expression Profile in Hepatocellular Carcinoma and Surrounding Tissue Predicts Time to Tumor Recurrence
Open Access
- 6 March 2018
- journal article
- research article
- Published by S. Karger AG in Liver Cancer
- Vol. 7 (3) , 277-294
Abstract
Background: The antitumor immune response may play a major role in the clinical outcome of hepatocellular carcinoma (HCC). We characterized the liver immune microKeywords
This publication has 53 references indexed in Scilit:
- Immunodominance and functional alterations of tumor-associated antigen-specific CD8+ T-cell responses in hepatocellular carcinomaHepatology, 2013
- T cell receptor signalling networks: branched, diversified and boundedNature Reviews Immunology, 2013
- Immunological and Molecular Correlates of Disease Recurrence after Liver Resection for Hepatocellular CarcinomaPLOS ONE, 2012
- Senescence surveillance of pre-malignant hepatocytes limits liver cancer developmentNature, 2011
- Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinomaGut, 2011
- Gene Expression in Fixed Tissues and Outcome in Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Focal Gains of VEGFA and Molecular Classification of Hepatocellular CarcinomaCancer Research, 2008
- Frequent Epigenetic Inactivation of Spleen Tyrosine Kinase Gene in Human Hepatocellular CarcinomaClinical Cancer Research, 2006
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003
- Statistical mechanics of complex networksReviews of Modern Physics, 2002